Literature DB >> 12526097

Macrophage colony-stimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-X(L).

Kyung Mi Woo1, Hyun-Man Kim, Jea Seung Ko.   

Abstract

Macrophage colony-stimulating factor (M-CSF) is known as one of the factors essential for osteoclast development. In the present study, we examined effects of M-CSF on the apoptotic pathway of osteoclast precursors and their underlying molecular mechanisms. Osteoclast precursors underwent apoptosis in the absence of M-CSF, even in the presence of receptor activator of NF-kappakB ligand (RANKL). Active caspase-3 and -9 were detected in the osteoclast precursors and treatments of precursors with their specific inhibitors (Z-DEVD-FMK and Z-LEHD-FMK) decreased the apoptosis. M-CSF decreased apoptosis in a dose-dependent manner with decreasing in active caspases-3 and -9 levels and up-regulating Bcl-X(L). Those effects of M-CSF on inhibiting apoptosis of osteoclasts precursor by regulating anti-apoptotic signals was more effective when combined with RANKL. These results demonstrate that M-CSF acts as a survival factor for the osteoclast precursors. Furthermore, it is believed that the apoptosis of osteoclast precursors may be involved in the activation of caspase-9 and that M-CSF may promote their survival through Bcl-X(L)-induced inhibition of caspase-9 activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12526097     DOI: 10.1038/emm.2002.48

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  12 in total

Review 1.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 2.  Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts.

Authors:  Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

Review 3.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

4.  NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors:  Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

5.  Differentiation analyses of adult suspension mononucleated peripheral blood cells of Mus musculus.

Authors:  Shahrul Hisham Zainal Ariffin; Intan Zarina Zainol Abidin; Muhammad Dain Yazid; Rohaya Megat Abdul Wahab
Journal:  Cell Commun Signal       Date:  2010-10-23       Impact factor: 5.712

6.  Signaling pathways in osteogenesis and osteoclastogenesis: Lessons from cranial sutures and applications to regenerative medicine.

Authors:  Justin B Maxhimer; James P Bradley; Justine C Lee
Journal:  Genes Dis       Date:  2015-01-09

7.  Staphylococcus Aureus Induces Osteoclastogenesis via the NF-κB Signaling Pathway.

Authors:  Li-Rong Ren; Zhi-Hua Wang; Hai Wang; Xiao-Qing He; Mu-Guo Song; Yong-Qing Xu
Journal:  Med Sci Monit       Date:  2017-09-24

8.  Staphylococcus aureus Protein A induces osteoclastogenesis via the NF‑κB signaling pathway.

Authors:  Li-Rong Ren; Hai Wang; Xiao-Qing He; Mu-Guo Song; Xue-Qiu Chen; Yong-Qing Xu
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

Review 9.  Immune regulation of bone loss by Th17 cells.

Authors:  Iannis E Adamopoulos; Edward P Bowman
Journal:  Arthritis Res Ther       Date:  2008-10-17       Impact factor: 5.156

10.  Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activation.

Authors:  Shiva Kant; Ajay Kumar; Sukh Mahendra Singh
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.